Home
ANIP
ANIP News

Latest ANI Pharmaceuticals Inc. (ANIP) News on September 18, 2025

Should ANI Pharmaceuticals’ (ANIP) Ambitious 2025 Revenue Forecast Prompt Action From Investors?

Simply Wall St.

5 days ago

Should ANI Pharmaceuticals’ (ANIP) Ambitious 2025 Revenue Forecast Prompt Action From Investors?

3 Reasons Why Growth Investors Shouldn't Overlook ANI (ANIP)

Zacks

10 days ago

3 Reasons Why Growth Investors Shouldn't Overlook ANI (ANIP)

Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?

Zacks

10 days ago

Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?

ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue?

Zacks

10 days ago

ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue?

The Top 5 Analyst Questions From ANI Pharmaceuticals’s Q1 Earnings Call

StockStory

3 months ago

The Top 5 Analyst Questions From ANI Pharmaceuticals’s Q1 Earnings Call

Argus Research

3 months ago

ANIP: Raising target price to $70.00

ANI Pharmaceuticals (NASDAQ:ANIP) Q1 Earnings: Leading The Generic Pharmaceuticals Pack

StockStory

3 months ago

ANI Pharmaceuticals (NASDAQ:ANIP) Q1 Earnings: Leading The Generic Pharmaceuticals Pack

3 of Wall Street’s Favorite Stocks with Questionable Fundamentals

StockStory

3 months ago

3 of Wall Street’s Favorite Stocks with Questionable Fundamentals

ANI Pharmaceuticals Announces Presentation of New Preclinical Data

GlobeNewswire

3 months ago

ANI Pharmaceuticals Announces Presentation of New Preclinical Data

3 Healthcare Stocks with Mounting Challenges

StockStory

3 months ago

3 Healthcare Stocks with Mounting Challenges

3 Cash-Producing Stocks in the Doghouse

StockStory

3 months ago

3 Cash-Producing Stocks in the Doghouse

ANIP Q1 CY2025 Earnings Call: Generics, Rare Disease Drive Growth; Retina Headwinds Noted

StockStory

3 months ago

ANIP Q1 CY2025 Earnings Call: Generics, Rare Disease Drive Growth; Retina Headwinds Noted

ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference

GlobeNewswire

4 months ago

ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference

3 Reasons to Avoid ANIP and 1 Stock to Buy Instead

StockStory

4 months ago

3 Reasons to Avoid ANIP and 1 Stock to Buy Instead

ANI Pharmaceuticals initiates Phase IV trial of gel for acute gout flares

Clinical Trials Arena

4 months ago

ANI Pharmaceuticals initiates Phase IV trial of gel for acute gout flares

1 Russell 2000 Stock with Solid Fundamentals and 2 to Steer Clear Of

StockStory

4 months ago

1 Russell 2000 Stock with Solid Fundamentals and 2 to Steer Clear Of

Generic Pharmaceuticals Stocks Q1 In Review: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs Peers

StockStory

4 months ago

Generic Pharmaceuticals Stocks Q1 In Review: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs Peers

MT Newswires

4 months ago

ANI Pharmaceuticals Launches Phase 4 Trial of Cortrophin Gel for Acute Gout Flares

ANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin® Gel for the Treatment of Acute Gout Flares

GlobeNewswire

4 months ago

ANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin® Gel for the Treatment of Acute Gout Flares

3 Value Stocks with Mounting Challenges

StockStory

4 months ago

3 Value Stocks with Mounting Challenges

Argus Research

4 months ago

ANIP: Lowering target price to $64.00

Pharmaceuticals Stocks Q1 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

StockStory

4 months ago

Pharmaceuticals Stocks Q1 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

Argus Research

4 months ago

ANIP: Lowering target price to $65.00

3 Small-Cap Stocks Walking a Fine Line

StockStory

4 months ago

3 Small-Cap Stocks Walking a Fine Line

ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ

GlobeNewswire

4 months ago

ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ

ANI (ANIP) is an Incredible Growth Stock: 3 Reasons Why

Zacks

4 months ago

ANI (ANIP) is an Incredible Growth Stock: 3 Reasons Why

ANI Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.

4 months ago

ANI Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations

GuruFocus.com

4 months ago

ANI Pharmaceuticals Inc (ANIP) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ...

Cortrophin Demand Is Soaring For ANI Pharma, CEO Says Well-Positioned To Mitigate Potential Tariff Impact

Benzinga

4 months ago

Cortrophin Demand Is Soaring For ANI Pharma, CEO Says Well-Positioned To Mitigate Potential Tariff Impact

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?

Zacks

4 months ago

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?

Compared to Estimates, ANI (ANIP) Q1 Earnings: A Look at Key Metrics

Zacks

4 months ago

Compared to Estimates, ANI (ANIP) Q1 Earnings: A Look at Key Metrics

MT Newswires

4 months ago

Sector Update: Health Care Stocks Flat to Higher Premarket Friday

MT Newswires

4 months ago

Top Premarket Gainers

ANI Pharmaceuticals (ANIP) Tops Q1 Earnings and Revenue Estimates

Zacks

4 months ago

ANI Pharmaceuticals (ANIP) Tops Q1 Earnings and Revenue Estimates

Associated Press Finance

4 months ago

ANI: Q1 Earnings Snapshot

MT Newswires

4 months ago

ANI Pharmaceuticals Q1 Adjusted Earnings, Revenue Rise; 2025 Outlook Raised

ANI Pharmaceuticals (NASDAQ:ANIP) Reports Strong Q1, Full-Year Outlook Slightly Exceeds Expectations

StockStory

4 months ago

ANI Pharmaceuticals (NASDAQ:ANIP) Reports Strong Q1, Full-Year Outlook Slightly Exceeds Expectations

ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance

GlobeNewswire

4 months ago

ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance

Pacira (PCRX) Q1 Earnings Surpass Estimates

Zacks

4 months ago

Pacira (PCRX) Q1 Earnings Surpass Estimates

ANI Pharmaceuticals Inc (ANIP) Q1 2025: Everything You Need To Know Ahead Of Earnings

GuruFocus.com

4 months ago

ANI Pharmaceuticals Inc (ANIP) Q1 2025: Everything You Need To Know Ahead Of Earnings

Earnings To Watch: ANI Pharmaceuticals (ANIP) Reports Q1 Results Tomorrow

StockStory

4 months ago

Earnings To Watch: ANI Pharmaceuticals (ANIP) Reports Q1 Results Tomorrow

Argus Research

4 months ago

ANIP: What does Argus have to say about ANIP?

ANI Pharmaceuticals to Report Q1 Earnings: Is a Beat in the Cards?

Zacks

4 months ago

ANI Pharmaceuticals to Report Q1 Earnings: Is a Beat in the Cards?

ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue?

Zacks

4 months ago

ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue?

ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis (EAU) Mouse Model

GlobeNewswire

4 months ago

ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis (EAU) Mouse Model

ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks

5 months ago

ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Generic Pharmaceuticals Stocks Q4 Teardown: Viatris (NASDAQ:VTRS) Vs The Rest

StockStory

5 months ago

Generic Pharmaceuticals Stocks Q4 Teardown: Viatris (NASDAQ:VTRS) Vs The Rest

1 of Wall Street’s Favorite Stock to Target This Week and 2 to Keep Off Your Radar

StockStory

5 months ago

1 of Wall Street’s Favorite Stock to Target This Week and 2 to Keep Off Your Radar

3 Reasons Growth Investors Will Love ANI (ANIP)

Zacks

5 months ago

3 Reasons Growth Investors Will Love ANI (ANIP)

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Zacks

5 months ago

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season?

Zacks

5 months ago

Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season?

Zacks.com featured highlights include Heritage Insurance, Marex, Kingstone, ANI Pharmaceuticals and HCI

Zacks

5 months ago

Zacks.com featured highlights include Heritage Insurance, Marex, Kingstone, ANI Pharmaceuticals and HCI

Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year?

Zacks

5 months ago

Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year?

Zacks.com featured highlights include ANI Pharmaceuticals, Heritage Insurance, Avista and Exelon

Zacks

5 months ago

Zacks.com featured highlights include ANI Pharmaceuticals, Heritage Insurance, Avista and Exelon

5 Stocks With Recent Price Strength Amid Tariff-Led Volatility

Zacks

5 months ago

5 Stocks With Recent Price Strength Amid Tariff-Led Volatility

Argus Research

5 months ago

ANIP: Lowering target price to $72.00

4 Stocks Trading Near 52-Week High With Room to Rise Further

Zacks

5 months ago

4 Stocks Trading Near 52-Week High With Room to Rise Further

MT Newswires

5 months ago

Truist Lifts Price Target on ANI Pharmaceuticals to $65 From $62, Keeps Hold Rating

ANI Pharmaceuticals, Inc. (ANIP) Soars to 52-Week High, Time to Cash Out?

Zacks

5 months ago

ANI Pharmaceuticals, Inc. (ANIP) Soars to 52-Week High, Time to Cash Out?

Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

StockStory

5 months ago

Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers

Argus Research

5 months ago

ANIP: Raising target price to $73.00

ANI Pharmaceuticals (ANIP): Buy, Sell, or Hold Post Q4 Earnings?

StockStory

5 months ago

ANI Pharmaceuticals (ANIP): Buy, Sell, or Hold Post Q4 Earnings?

IBD 50 Stock Flashes 'Golden Cross' But Massive Risk Looms

Investor's Business Daily

5 months ago

IBD 50 Stock Flashes 'Golden Cross' But Massive Risk Looms

VALN Doses First Infant With Shigella Vaccine in Mid-Stage Study

Zacks

5 months ago

VALN Doses First Infant With Shigella Vaccine in Mid-Stage Study

3 Reasons Why Growth Investors Shouldn't Overlook ANI (ANIP)

Zacks

5 months ago

3 Reasons Why Growth Investors Shouldn't Overlook ANI (ANIP)

Will ANI (ANIP) Beat Estimates Again in Its Next Earnings Report?

Zacks

5 months ago

Will ANI (ANIP) Beat Estimates Again in Its Next Earnings Report?

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks

5 months ago

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET

GlobeNewswire

5 months ago

ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET

Argus Research

5 months ago

ANIP: Lowering target price to $66.00

Zacks.com featured highlights ANI Pharmaceuticals, Expand Energy, Avista Corp and Contango ORE

Zacks

5 months ago

Zacks.com featured highlights ANI Pharmaceuticals, Expand Energy, Avista Corp and Contango ORE

Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?

Zacks

5 months ago

Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?

Tariff Woes? Play Safe With 4 Low-Beta Stocks: ANIP, EXE, AVA & CTGO

Zacks

5 months ago

Tariff Woes? Play Safe With 4 Low-Beta Stocks: ANIP, EXE, AVA & CTGO

Is the Options Market Predicting a Spike in ANI Pharmaceuticals (ANIP) Stock?

Zacks

5 months ago

Is the Options Market Predicting a Spike in ANI Pharmaceuticals (ANIP) Stock?

3 Russell 2000 Stocks in the Doghouse

StockStory

6 months ago

3 Russell 2000 Stocks in the Doghouse

Zacks.com featured highlights include HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree

Zacks

6 months ago

Zacks.com featured highlights include HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree

Argus Research

6 months ago

ANIP: Raising target price to $71.00

5 Relative Price Strength Stocks to Navigate Today's Market

Zacks

6 months ago

5 Relative Price Strength Stocks to Navigate Today's Market

ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference

GlobeNewswire

6 months ago

ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference

Argus Research

6 months ago

ANIP: Raising target price to $70.00

5 Top-Ranked Mid-Cap Stocks to Buy for a Stellar Portfolio

Zacks

6 months ago

5 Top-Ranked Mid-Cap Stocks to Buy for a Stellar Portfolio

Is ANI (ANIP) a Solid Growth Stock? 3 Reasons to Think "Yes"

Zacks

6 months ago

Is ANI (ANIP) a Solid Growth Stock? 3 Reasons to Think "Yes"

Wall Street Analysts Think ANI (ANIP) Could Surge 26.83%: Read This Before Placing a Bet

Zacks

6 months ago

Wall Street Analysts Think ANI (ANIP) Could Surge 26.83%: Read This Before Placing a Bet

Should You Buy ANI Pharmaceuticals (ANIP) After Golden Cross?

Zacks

6 months ago

Should You Buy ANI Pharmaceuticals (ANIP) After Golden Cross?

Is Corcept Therapeutics (CORT) Stock Outpacing Its Medical Peers This Year?

Zacks

6 months ago

Is Corcept Therapeutics (CORT) Stock Outpacing Its Medical Peers This Year?

MT Newswires

6 months ago

Ani Pharmaceuticals Launches Nitazoxanide Tablets for Treating Diarrhea

ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets

GlobeNewswire

6 months ago

ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets

Teva Pharmaceutical Stock Scores RS Rating Upgrade

Investor's Business Daily

6 months ago

Teva Pharmaceutical Stock Scores RS Rating Upgrade

MT Newswires

6 months ago

ANI Pharmaceuticals Completes Buyout of Royalty Obligation for Iluvien, Yutiq

ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ®

GlobeNewswire

6 months ago

ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ®

Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment

StockStory

6 months ago

Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment

MT Newswires

6 months ago

ANI Pharmaceuticals Says FDA Approves Expanded Label for Iluvien

MT Newswires

6 months ago

Jefferies Initiates Coverage on ANI Pharmaceuticals With Buy Rating, $80 Price Target

ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label

GlobeNewswire

6 months ago

ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label

Relative Price Strength: A Smart Strategy Amid Market Turmoil

Zacks

6 months ago

Relative Price Strength: A Smart Strategy Amid Market Turmoil

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

StockStory

6 months ago

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

BIIB Starts Felzartamab Phase III Study in AMR in Kidney Transplant

Zacks

6 months ago

BIIB Starts Felzartamab Phase III Study in AMR in Kidney Transplant

Zacks.com featured highlights include ANI Pharmaceuticals, Dana, Pitney Bowes, Priority Technology and Kingstone

Zacks

6 months ago

Zacks.com featured highlights include ANI Pharmaceuticals, Dana, Pitney Bowes, Priority Technology and Kingstone

1 Growth Stock to Target This Week and 2 to Avoid

StockStory

6 months ago

1 Growth Stock to Target This Week and 2 to Avoid

MT Newswires

6 months ago

JPMorgan Initiates ANI Pharmaceuticals at Overweight With $85 Price Target

MT Newswires

6 months ago

Ani Pharmaceuticals Insider Sold Shares Worth $323,049, According to a Recent SEC Filing

Share on Social Networks: